Literature DB >> 580065

Integration of modern data in W.H.O. categorisation of lymphosarcomas. Its value for prognosis prediction and therapeutic adaptation to prognosis.

G Mathé.   

Abstract

The categorisation of lymphosarcomas with immune markers has enriched the prognostic value of W.H.O. classification. The prolymphocytic (centrofollicular B type and the null lymphoblastic subtype have a good prognosis while the (T or B) immunoblastic type and the T-lymphoblastic subtype have a poor prognosis.

Entities:  

Mesh：

Year:  1977        PMID： 580065

Source DB:  PubMed          Journal:  Biomedicine        ISSN： 0300-0893


  2 in total

1.  Chemotherapists' need for uniform and rational nomenclature and classification of common lymphosarcomas and reticulosarcoma (hematosarcomas or non-Hodgkin's lymphomas).

Authors:  G Mathé
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation.

Authors:  J L Misset; G Mathé; M Tubiana; B Caillou; F de Vassal; P Pouillart; M Gil; C Tentas; M Hayat; L Schwarzenberg; C Jasmin; M Delgado; D Machover; P Ribaud; M Musset
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.